|
|
|||
Serevent Lawsuits
When the
FDA approved the drug Serevent for the
treatment of asthma in 1994, they were unaware of the problems to come. Serevent, manufactured by GlaxoSmithKline, later had its FDA-approved use
extended to include treatment of chronic obstructive pulmonary heart
disease. Used daily, Serevent controls the symptoms of asthma and is
considered a long-acting bronchodilator. According to Serevent marketing
material, the medication provides up to twelve hours of relief from chest
tightness and wheezing related to asthma and other chest conditions. While
Serevent enjoys great popularity with asthma victims, many users remain
unaware that a recent study showed that users of Serevent are three times
more likely to die asthma-related deaths as users of other asthma
medications. |
|||
|
|